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 Abstract 
 
Despite a growing understanding of the impact of fat and protein on post-prandial blood glucose 
levels, current medical nutrition therapy for treatment of type 1 diabetes continues to focus 
primarily on carbohydrate counting for mealtime bolus calculation. Standards of care practice 
guidelines suggest increasing mealtime dose for meals high in fat and/or protein, but do not 
provide specific guidelines on adjustment of insulin dose and timing for high fat and/or protein 
meals. There is no recommended macronutrient breakdown for patients with type 1 diabetes, 
who may follow a variety of diets and dietary patterns.  Both low carbohydrate diets and higher 
carbohydrate plant-based diets have increased in popularity over recent years, revealing 
variability in individual response to diet composition and the role of various dietary components 
beyond solely carbohydrate content on glycemic control.   Variability in response to various 
dietary components suggests the need for individually tailored dietary education to develop 
effective mealtime dosing strategies that improve glycemic control within the context of each 
individual’s dietary preferences and responses. Therefore, this review examines recent research 
on the impact of dietary fat and protein on post-prandial blood glucose, discusses the current 
evidence for different mealtime dosing strategies that account for dietary fat and protein, and 
suggests critical areas for future work with the goal of improving postprandial blood glucose in 
patients with type 1 diabetes. 
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 Introduction  
Despite a growing consensus that dietary fat and protein impact post-prandial blood glucose 
levels, current medical nutrition therapy for treatment of type 1 diabetes continues to focus solely 
on carbohydrate-counting for mealtime bolus calculation.  A 2015 systematic review on the 
impact of fat and protein on postprandial blood glucose control in patients with type 1 diabetes 
concluded that both fat and protein significantly modified postprandial glycemia in all studies 
included in the review, and recommended that mealtime insulin doses be adjusted based on the 
complete composition of meals rather than solely on carbohydrate content.(1)  
Since 2015, CGM use has increased by 23% and an automated insulin system has been approved 
in the United States, allowing for increased insight into dose adjustment for dietary fat and 
protein.(2) As continuous glucose monitoring becomes standard of care for type 1 diabetes 
management, and hybrid closed-loop systems become increasingly available, in-range 
postprandial blood glucose levels may become more feasible.  
Recent standards of care practice guidelines have suggested increasing mealtime dose for meals 
high in fat and/or protein, but do not provide specific guidelines on dose adjustment and dose 
timing for high fat or protein meals.(3) The 2019 ADA consensus report on nutrition therapy for 
adults with diabetes or prediabetes states that, “When consuming a mixed meal that contains 
carbohydrate and is high in fat and/or protein, insulin dosing should not be based solely on 
carbohydrate counting. A cautious approach to increasing mealtime insulin doses is suggested; 
continuous glucose monitoring (CGM) or self-monitoring of blood glucose (SMBG) should 
guide decision-making for administration of additional insulin.”(4) However, adjusting mealtime 
insulin dose to account for complete meal composition is complex, highly variable based on 
individual response, and therefore rarely incorporated into clinical practice.   
The availability of new technology has allowed for the development and testing of different 
strategies for mealtime insulin dosing that account for macronutrient composition; however, to 
our knowledge, no studies have considered the potential translation of these dosing models 
within the context of what is currently understood about the glycemic response to dietary fat and 
protein, individual variability, and various commercially available insulin delivery systems. 
While glycemic index (GI) and glycemic load (GL) have also been indicated in postprandial 
glycemic response, this review focuses on the effects of fat and protein, and does not specifically 
address the impact of different types of carbohydrate on postprandial glycemia.  Therefore, the 
purpose of this review is to address the following questions: what is known about how fat and 
protein impact blood glucose; what effects do fat, protein, and mixed meals have on postprandial 
blood glucose levels in people with type 1 diabetes; what new dosing models have been 
proposed; and what are critical areas for future work and implications for clinical practice. 
Current Status of Knowledge 
I. Proposed Mechanisms of Dietary Fat and Protein Impact on Blood Glucose 
 
Figure 1-   
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Dietary fat and protein impact blood glucose through a variety of complex interconnected 
mechanisms. Postprandial glycemia is determined primarily by several interrelated factors: 
digestion and absorption of simple sugars by salivary enzymes, rate of gastric emptying, 
preprandial glycemic levels, macronutrient composition of meal, intestinal absorption, hepatic 
glucose production, degree of insulin resistance, and insulin secretion or provision of exogenous 
insulin. Dietary fat has been shown to impair insulin sensitivity and enhance hepatic glucose 
production in addition to delaying gastric emptying, while dietary protein is primarily thought to 
influence blood glucose via modulation of hepatic glucose production.   
 
Amino acids are thought to impact blood glucose in people with type 1 diabetes by modulating 
hepatic glucose production both directly and indirectly.  In healthy subjects, dietary proteins and 
amino acids are known to have an insulinotropic effect, promoting secretion of insulin from 
pancreatic beta cells; however, in animal models and patients with type 2 diabetes, high protein 
diets have been shown to increase hepatic glucose production.(5) Some amino acids can 
contribute to gluconeogenesis as substrates, have the ability to stimulate glucagon and, among 
those with remaining beta cell function, insulin secretion.  Furthermore, amino acids can 
interfere with the ability of insulin to repress endogenous glucose production.  High protein 
intake may increase hepatic glucose production; however, further studies are needed to address 
 the impact of type of protein/amino acid composition on blood glucose.(5, 6) 
 
Dietary studies on both type 1 diabetes and type 2 diabetes have shown that fat delays gastric 
emptying.(7, 8) Rate of gastric emptying occurs in a biphasic pattern and is determined by the 
integration of motor activity and electrical signaling, and regulated by a complex system of 
metabolic, neuronal, and endocrine signals.(7) After ingestion of a meal, a gastric pacemaker 
located in the upper part of the stomach generates a slow-wave basal rhythm, and tonic 
contraction redistributes solids to the distal stomach. The lag phase consists of redistribution and 
breakdown of solids from the gastric fundus, which pass through the pylorus during the second 
phase known as the lineal emptying phase. Remnants are then delivered more slowly to the 
duodenum, which is regulated by a negative feedback mechanism mediated by the incretin 
hormones: cholescystokinin (CCK), glucagon-like peptide-1 (GLP-1), and peptide YY (PYY).(9)  
 
Dietary triglycerides stimulate intestinal release of incretin hormones via binding to G-protein-
coupled receptors (GPCR) on intestinal mucosal L cells.  Studies suggest that 2-
monoacylglycerol, short-chain fatty acids (SCFAs), and medium and long chain fatty acids 
stimulate GLP-1 secretion via this mechanism.(10, 11) Products of protein breakdown may also 
stimulate GLP-1 secretion; however, the mechanism is poorly understood.(11) PYY, which is 
also released from L cells of the intestinal mucosa, exerts a similarly inhibitory effect on gut 
motility via inhibition of gastric acid secretion.  Studies in animal models and in individuals with 
obesity suggest that a high fat diet stimulates PYY secretion to a greater extent than protein and 
carbohydrates.(12, 13) 
 
Dietary fat may also modulate other gastrointestinal hormones involved in gastric emptying like 
ghrelin, a peptide hormone that originates primarily from the stomach, and stimulates growth 
hormone release, prolactin, adrenocorticotropic hormone (ACTH), and cortisol.  Ghrelin has 
been shown to stimulate appetite in humans, but also modulates gastric motility, and studies have 
shown an increase in gastric emptying after ghrelin administration in normal weight non-diabetic 
individuals.(14) Ghrelin also directly stimulates glucagon secretion from pancreatic alpha-cells, 
reducing insulin sensitivity and increasing hepatic glucose production.(15) Feeding studies in 
both animal models and normal weight individuals without diabetes suggest that ghrelin is 
suppressed less effectively and more slowly by dietary fat than by carbohydrates and protein, 
suggesting that ghrelin may play a role in the modulation of gastric emptying by dietary fat.(16-
18) 
 
While it is well established that dietary fat increases post-prandial blood glucose levels, the 
impact of type of dietary fat on blood glucose and insulin sensitivity remains somewhat 
controversial.  A number of studies have linked insulin resistance and hepatic glucose production 
with free fatty acids.(19) (20)  On the other hand some studies have suggested that a diet rich in 
unsaturated fat, specifically polyunsaturated fat (PUFAs) is beneficial for blood sugar 
regulation.(21) Consumption of meals high in saturated fats is associated with increased insulin 
resistance when compared with meals high in monounsaturated and polyunsaturated fats, and 
monounsaturated fats have been shown to delay gastric emptying to a greater extent when 
compared with saturated fat.(22)  
 
 An additional factor involved in rate of gastric emptying and postprandial blood glucose is 
preprandial blood glucose level.  Acute and chronic hyperglycemia has been shown to decrease 
rate of gastric emptying. Additionally, many people with diabetes (both type 1 and type 2) may 
experience delayed gastric emptying; however, reported estimates from the T1D Exchange clinic 
registry suggest that only approximately 4.8% of registry participants have a clinical diagnosis of 
gastroparesis.(23) Both individual and inter-individual variability in glycemic response to dietary 
fat and protein are important considerations when establishing mealtime dosing guidelines. 
 
II. Effects of Fat, Protein, and Mixed Meals on postprandial blood glucose levels in people 
with type 1 diabetes 
 
Research on Fat  
Multiple studies published within the last ten years in patients with type 1 diabetes using 
continuous glucose monitors (CGMs) have concluded that dietary fat increases post-prandial 
blood glucose levels and/or insulin requirements.(24-29) This trend persists in some studies 
utilizing hybrid closed loop systems, suggesting the need to consider dietary fat content in 
mealtime dosing strategies regardless of technology utilized by patients with type 1 diabetes.(27)  
High fat meals appear to cause sustained delayed postprandial glycemia.  Bell et. al found that 
increasing dietary fat by 20 g significantly reduced early (0-2 hour) postprandial glucose 
response and significantly raised late (2-5 hour) post-prandial glycemic response when compared 
with the low fat (0 g fat) meal.  Response was dose-dependent.(24) Wolpert et. al. similarly 
found that a high fat meal (60 g) significantly increased insulin needs by 42% 5-10 hours after a 
meal with use of a closed loop algorithm when compared with a low fat (10 g) meal.  Noted 
individual differences were significantly correlated with individual daily insulin 
requirements.(27) While there is a trend across studies that addition of dietary fat results in 
delayed post-prandial hyperglycemia, both studies noted a high amount of variability in 
individual response to dietary fat in meals.(24, 27)  Variability in response to dietary components 
is relevant when considering dose-adjustment for dietary fat. 
Consideration of dietary fat in mealtime dose may also be relevant within the context of 
emerging technology for people with type 1 diabetes.  In fact, it appears that not all hybrid closed 
loop algorithms are able to account for increased insulin needs post consumption of a high fat 
meal. A recent study in 7 participants with type 1 diabetes used a crossover design to examine 
18-hour periods on a closed loop system post a high fat (60 g predominantly saturated fat) versus 
a low fat (10 g) meal.  Within the context of this closed loop system, the high fat dinner 
increased mean insulin requirement by 42% with noted individual differences.  Post-prandial 
plasma glucose and area under curve (AUC) despite additional insulin were significantly higher 
for participants after consuming the high fat meal compared with the low fat meal.(27) This 
suggests that not all algorithms may effectively account for increased insulin needs from high fat 
meals, and dosing strategies may need to be adjusted for high fat meals even with hybrid closed 
loop algorithms. 
While a number of studies have examined the impact of high fat versus low fat meals on post-
prandial hyperglycemia, only a handful of studies have examined the impact of different types or 
 sources of dietary fat on postprandial blood glucose. Bell et. al. examined response to test meals 
containing the same carbohydrate content but differing foods containing various fat types.  The 
foods were: avocado which is high in monounsaturated fat, margarine which contains 
polyunsaturated fatty acids, or butter a source of mostly saturated fat.  Bell et. al. found no 
significant difference in five hour incremental area under curve (iAUC) for the different fat 
sources.(24) Another study comparing the addition of extra-virgin olive oil (EVOO), butter, or a 
low fat meal found that iAUC was lower after the EVOO test meal than the low fat or butter test 
meals. Bozzetto et. al. also reported gastric antrum volume significantly larger 60-90 min (1-1.5 
hrs.) post-prandially, and significantly smaller 330-360 min (5.5-6 hrs.) after consumption of the 
EVOO meal when compared to the butter meal.  Postprandial GLP-1 iAUC was also 
significantly higher after the EVOO meal when compared with the other meals.  Finally, 
triglyceride iAUC was significantly higher after the EVOO meal when compared with the butter 
meal.(25) These results suggest that type of fat may differentially affect rate of gastric emptying, 
time to peak glucose, and post-prandial blood glucose level; however, currently there is 
insufficient evidence to inform dosing recommendations based on fat source/type.  More 
research is needed to assess glycemic response to both types of fat and specifically to various 
food sources of fat. 
Research on Protein  
The impact of protein on postprandial glycemia is less consistent, and appears to be dependent in 
part on quantity and macronutrient content of meal. While most studies report significant 
differences in glycemia with the addition of protein to a standard meal, protein appears to have 
different effects when consumed with and without carbohydrates.(1)  
Glycemic response to protein may depend on quantity consumed.  A recent within subject 
randomized crossover trial in 25 children and adults utilizing CGM data compared consumption 
of whey isolate protein drinks (varying g protein, 0 g carbohydrate, 0 g fat) to two 150 ml (10 g 
and 20 g glucose) glucose drinks. Authors found that consumption of greater than or equal to 75 
g of protein significantly increased postprandial glycemia 3-5 hours after onset of the meal in 
comparison with the control 0 g protein drink.  Compared with the 20 g glucose drink, glycemic 
excursion following consumption of greater than or equal to 75 g protein did not commence until 
90 minutes and reached the same level as the 20 g glucose at 180 minutes (3 hours) compared to 
60 minutes (1 hour).(30) This suggests that consumption of protein alone (unaccompanied by 
carbohydrates or fat) may only significantly impact blood glucose when consumed in large 
quantities (>75g). 
Another study compared two similar test meals one with an additional 21.5 g of protein from 
non-fat fromage fraiche in 28 patients with type 1 diabetes.  Control meal included 40 g protein, 
37 g fat, and 90 g carbohydrate.  Insulin doses were maintained across the two evening meals 
consumed on consecutive days.  Capillary glucose was measured before, and 2 hrs. post-meal, 
along with continuous glucose monitoring.  Authors found no difference in mean interstitial 
glucose or in capillary glucose for the 12 hours following the meal with added protein compared 
to the standard meal.  The AUC was also similar across meals.(31) It may be that 21.5 g of 
protein was insufficient to significantly impact blood glucose.  Effects may only be evident with 
multiple servings of protein (for example 75 g is equivalent to approximately 10 oz. of red meat). 
 Research on Mixed Meals 
Given that many foods containing fat also contain protein, a number of studies examined the 
impact of sources of both fat and protein on post-prandial glycemia.  Meals that are high in fat 
and protein require significantly more insulin than low fat low protein meals with the same 
amount of carbohydrates.  In a study of 10 adults with type 1 diabetes, Bell et. al. found that a 
high fat high protein meal (44 g fat, 36 g protein) increased glucose iAUC over twofold and 
required an additional 65% more insulin when compared with a low fat low protein (4 g fat, 9 g 
protein) test meal.(32) Another study in 15 adolescents with type 1 diabetes compared a standard 
meal to a high fat high protein meal (36 g fat, 34 g protein) over two consecutive days.  Insulin 
was dosed using insulin to carb ratios, and blood glucose was measured for 12 hours after 
consumption of the meals.  Gingras et. al. found a significant difference in AUC between 4-12 
hours post-meal.  Maximum AUC difference occurred at 6 hours after the meal, and glucose 
concentration 12 hours after the meal remained higher after the high fat high protein meal than 
after the standard meal.(33) This shows that a high fat high protein meal requires significantly 
more insulin than a low carbohydrate meal, and that the effect may be most notable at least 4 
hours after eating.   
While some closed loop systems may be able to address increased insulin needs after a high fat 
high protein meal, they help highlight differences in time to glycemic peak and give insight into 
optimized insulin dosing.  Gingras et. al examined fat and protein added to standard meals using 
a closed loop insulin delivery system in 15 adults with type 1 diabetes.  The meals were as 
follows: (1) carbohydrate-only (standard 75 g CHO, 1 g fat, 7 g protein), (2) high protein (HP 1 g 
fat, 35 g protein), (3) high fat (HF 10 g protein, 33 g fat) and (4) high fat high protein (HFHP 36 
g fat, 34 g protein).  Addition of fat and/or protein to test meal with fixed carbohydrate content 
significantly increased time to glycemic peak by 40 minutes and increased post-meal insulin 
delivery. Five-hour post-meal basal insulin required 39% more insulin after the high fat high 
protein meal when compared to the standard meal; however, 5-hour post-meal sensor glucose 
area under curve was not significantly impacted by the addition of fat and protein.(33) While the 
algorithm appeared able to adjust for fat and protein in the test meal, insulin requirements were 
significantly increased for multiple hours post meal, important considerations when determining 
dosing and delivering medical nutrition therapy to patients with type 1 diabetes. 
Another important consideration is that high fat high protein meals may include different foods 
with varying nutrient compositions, which may in turn impact blood glucose apart from simple 
macronutrient composition.  One study looked at 2-hour blood glucose (BG), area under curve 
(AUC), and BG range after various takeout meals in 9 individuals with type 1 diabetes.  The 
meals were as follows: high fat pasta meal, Thai meal, a hamburger meal, and a cheese 
sandwich.  Authors found that BG range and AUC was lower after the HF pasta meal when 
compared with the other meals, but found no significant differences between sandwich, Thai, and 
a hamburger meal.(34) It is important to point out that, given the results from previous studies on 
fat and protein, significant differences may not have been noted within 2 hours post-meal.  While 
this paper focuses on the impact of fat and protein on blood glucose, more research on various 
meal compositions is warranted, with blood glucose measured for at least 5 hours post-meal. 
III. Mealtime Dosing Models 
  
Table 1 Description of Dosing Models  
Model Name Description of Dose Model Comparison of Model with Insulin to Carb Ratio 
Model 
Predicted 
Bolus (MPB) 
Estimator 
 
Bell et. Al.( 
24, 32) 
2-step individualized model:   
Step 1: metabolic model comprising of 
insulin 
pharmacokinetic/pharmacodynamics 
model Bergman minimal model, and 
piecewise linear approximation of 2nd 
order meal absorption.  
Step 2 optimal insulin dose, split, and 
duration obtained by minimizing 
model-predicted glucose area below 
target 0-120 minutes and above target 
120-360 minutes post-meal 
 
Optimal pattern and Timing: Varies 
based on individual and amount of fat 
in meal.   
Delivery patterns range from 10%/90% 
to 50%/50% split, with the extended 
bolus lasting from 2 to 3 h 
Average was a dual-wave bolus with a 
30%/70% split over 2.4 hrs.( 32) 
20-g fat meal: 75/25% split over 11/ 4 h  
40-g fat meal: 65/35% split over the 
same time period  
60-g fat meal: 50/50% split over 13/4 
hrs.( 24) 
Study 1(32): 
Compared with Insulin to Carb Ratio 
delivered as a 50%/50% combination 
bolus over 2 hours: 
Meals: LFLP v. HFHP (+ 40 g fat, + 27 g 
protein) 
Insulin Dose: + 65% ± 10%  
iAUC difference: MPB decreased the 
glucose iAUC from 27,092 ± 1,709 
mg/dL ⋅ min to 11,712 ± 3,172 mg/dL ⋅ 
min (P = 0.0013)  
Incremental change in blood glucose: 
73 ± 4 mg/dL to 24 ± 11 mg/dL (P = 
0.001) 
Inter-individual Variability: insulin 
needs +17%–+124%; 8 of the 10 subjects 
requiring 75% or more insulin 
Hypoglycemia: 
MPB initially too high in 2/10 subjects 
Study 2 (24): 
Compared with Insulin to Carb 
Ratio delivered as a 50%/50% 
combination bolus over 2 hours 
15 min prior to meal: 
Meal types: 0g v. 20 g v. 40 g fat 
(MUFA v. PUFA v. SFA) 
Mean Insulin Dose: +6% (20 g 
fat), + 6% (40 g fat), +21% (60 g 
fat)  
iAUC difference: -50% (20 g 
fat), -35% (40 g fat), -58% (60 g 
fat)  (<.001) 
Inter-individual Variability: 
Difference in insulin needs ranged 
from -64% to +29% (20 g fat), -
16% to +18% (40 g fat) -28% to 
+34% (60 g fat)  
Hypoglycemia: Not significant, 
Relative risk between ICR and 
MPB dose 0.941 (95% CI 0.437–
1.963; P > 0.999) 
Food Insulin 
Index (FII)( 
35, 38) 
Algorithm that ranks foods based on 
insulin demand in healthy subjects.( 35) 
 
FID = FII x KJ per serving and dividing 
by 1000 KJ (FII x KJ per serving/1000)  
Study 1:   
Triple-blinded randomized w/in subject 
crossover (36) 
Meals: Six foods: steak, battered fish, 
poached eggs, low-fat yoghurt, baked 
beans and salted peanuts 
Time to peak glucose: 34±5 min (FII) 
56±7 min (ICR) 
P=0.007 
Peak BG Excursion: 1.3±0.2mmol/L 
(FII) 1.8±0.3 mmol/L (ICR)  
 (P=0.13) 
Mean Change in BG:   
-12% / 3 hours −0.7±0.2 mmol/L (FII) 
0.1±0.2 mmol/L (ICR) 
(P=0.001) 
Hypoglycemia: Mild hypoglycemia 
occurred in 48% (FII) vs. 33% (ICR) of 
all test sessions 
(P=0.155) 
Study 2:  
Compared Carbohydrate counting 
to FII algorithm.( 37) 
Meals: 2 breakfast equal kcal, 
and FII (FII=60), but different 
Carbohydrates (75 g v. 41 g) 
TIR: +31% (p= 0.001) 
iAUC difference: -52%, (p= 
0.013) 
Time to peak glucose: 
59 min (FII) 
97 min (ICR) 
(P=0.002) 
Peak BG excursion: 
-41% 
2.4 ± 1.9 mmol/L (FII) 
4.1 ± 3.1 mmol/L (ICR) 
(P =0.01) 
Hypoglycemia: No significant 
difference in occurrence of 
hypoglycemia for either meal. 
11 episodes (ICR) 
6 episodes (FII) 
(Meal A: P= 0.57) 
(Meal B: P= 0.31) 
  
Currently, mealtime insulin dose is typically calculated by dividing amount of carbohydrate in a 
meal by an individual’s insulin to carbohydrate ratio (ICR). Multiple mealtime dosing models for 
dietary fat and protein have been proposed (table 1), but only a few studies have evaluated the 
efficacy of these models in accounting for delayed post-prandial glycemic response, and only 
one study has compared these dosing models in patients with type 1 diabetes. 
One proposed dosing model utilizes a dual wave bolus based on predicted individual response 
where a percentage of the dose is given immediately and the rest is given over time for high fat 
high protein meals.  The adaptive Model Predictive Bolus (MPB) algorithm consists of a 2-step 
individualized model.  Step 1 includes a metabolic model comprising of an insulin 
pharmacokinetic/pharmacodynamics model (the Bergman minimal model), and a piecewise 
linear approximation of 2nd order meal absorption.  In step 2, optimal insulin dose, split and 
duration are obtained by minimizing model-predicted glucose area below target 0-120 minutes 
(0-2 hours) and above target 120-360 minutes (2-6 hours) post-meal.  The MPB algorithm was 
evaluated in a study of 10 patients with type 1 diabetes.  Bell et. al. found that a high fat high 
protein meal increased glucose iAUC over twofold and required an additional 65% more insulin, 
however, there was a large amount of variability with regards to insulin needs (+/- 10%).  In two 
studies comparing MPB to dosing based on insulin to carb ratio, use of the MPB reduced iAUC 
significantly by at least 50%.(24, 32) In one study, hypoglycemia occurred in 2/10 participants, 
requiring adjustments to the model.(32) Bell et. al however found that when compared with 
dosing based on ICR, there was no significant difference in relative risk of hypoglycemia.(24) 
While the model accounts for individual differences in response to macronutrient composition 
Warsaw Pump 
Therapy 
School 
(Warsaw 
formula/ 
Pankowska 
Equation) 
Extended bolus comprised of number of 
Fat protein units (1 FPU  = 100 kcal of 
fat and/or protein) multiplied by the 
insulin ratio (IR), which is defined as 
the dose of insulin that covers 10 g 
CHO or 100 kcal of fat and protein.( 
39) 
 
Timing of bolus determined based on 
the number of FPU, beginning with 3 
hours for a meal containing 1 FPU (100 
kcal from fat or protein) to 8 hours for a 
meal containing more that 3 FPU (300 
kcal from fat or protein) 
Study 1: Randomized controlled cross-
over (40) 
Meals: SM (70 g CHO, 24 g protein, 17 
g fat) v. 3 test meals HPM (70 g CHO, 36 
g protein, 17 g fat), HPFM using ICR, 
HPFM using FPU (both 70 g CHO, 36 g 
protein, 30 g fat) 
Total AUC:  
ICR 53 275 mg/dLxdk 
FPU 45 253 mg/dL x dk 
(P=0.085) 
Early AUC (0-120 min): 
27 289 mg/dl x dk (ICR) 
24 644 mg/dlx dk (FPU) 
(p= 0.405) 
Late AUC (120-240 min): 
25 986  mg/dl x dk (ICR) 
20 609 mg/dlx dk (FPU) 
(p= 0.032) 
Time to Peak Glucose: 
90 min for both ICR & FPU 
Peak Glucose:  
251.93 (ICR) 
225.00 (FPU) 
(p= 0.227) 
 
 and utilizes modeling to predict insulin needs for high fat high protein meals, there may be 
challenges to implementing this dosing model in other settings. 
  
Another dosing model is based on insulin response to specific foods in healthy individuals.  The 
Food Insulin Index (FII) is a database containing more than 120 foods that ranks foods by 
relative insulin demand.  It was developed in healthy subjects, and looked at relative dietary 
insulin demand generated by 1,000-KJ portions of foods. (35) Bell et. al compared carbohydrate 
counting for mealtime insulin dose to dose based on the estimated food insulin demand (FID), 
which is calculated by multiplying FII by KJ per serving and dividing by 1000 KJ (FII x KJ per 
serving/1000) in 15 adults with type 1 diabetes.  For the purpose of the study, FID was scaled up 
by a factor of 100/59 (the FID of the reference food pure glucose) so that insulin to carb ratio in a 
pump could be utilized to calculate dose. Mean blood glucose levels after 180 minutes post meal 
were significantly lower when FII algorithm was used to calculate prandial dose when compared 
with carbohydrate counting (5.7 ± 0.2 vs. 6.5 ± 0.2 mmol/l, P = 0.003), and mean change in 
blood glucose level over 3 hours was also significantly lower (−0.7 ± 0.2 vs. 0.1 ± 0.2 mmol/l, P 
= 0.001).(36) The NIDDA (Normal Insulin Demand for Dose Adjustment) study also compared 
dose based on FII algorithm to insulin dose based on conventional carbohydrate counting in 28 
adults with type 1 diabetes on insulin pump therapy.  Bao et. al found that use of the FII 
algorithm improved time in range, and reduced post-prandial peak in blood glucose when 
compared with dose based on carbohydrate counting.  No significant difference in hypoglycemia 
was noted between ICR and FII (Table 1).(37) One limitation of this model is that not all foods 
are available in the database, which limits the applicability of this model among patients that 
may consume foods not listed in the database.  Additionally, due to the complexity of 
calculations required, patients may find it challenging and/or burdensome to implement. 
 
The Warsaw Pump Therapy School or the Warsaw formula/Pankowska equation is another 
formula that accounts for fat and protein in mealtime dose calculation.  The formula utilizes a 
standard insulin-carb ratio and an additional insulin-to-fat-protein ratio.  Insulin is given for 
carbs immediately, and for fat and protein using an extended bolus comprised of number of fat 
protein units (1 FPU  = 100 kcal of fat and/or protein) multiplied by the insulin ratio (IR).  Dose 
timing is determined based on the number of FPU, beginning with 3 hours for a meal containing 
1 FPU (100 kcal from fat or protein) up to 8 hours for a meal containing more that 3 FPU (300 
kcal from fat or protein).(39) Utilizing this formula, Pankowska et. al described a bolus 
calculator that included a food database, and utilized the Warsaw Pump Therapy School formula 
to develop an algorithm for prandial insulin calculation.(41) A recent randomized controlled trial 
evaluated this algorithm compared to doses based on insulin to carb ratios in 30 adolescents with 
type 1 diabetes after consumption of test meals ranging in macronutrient composition.  Kaya et. 
al found that blood glucose levels were significantly higher after consumption of the high fat 
high protein meal when only insulin to carb ratio was used for dose compared with the addition 
of the insulin-fat ratio at 120-240 minutes (2-4 hours) post meal.(40) The Warsaw formula 
allows for dosing based solely on macronutrient content without predictive modeling or a 
reference database; however, it may not adequately account for individual differences in 
response to different foods. 
 
Only one study has compared these dosing models, and found that the Pankowska equation 
better reduced postprandial hyperglycemia after high fat and high protein meals. Lopez et. Al. 
 evaluated three prandial insulin-dosing algorithms in 33 children and adolescents with type 1 
diabetes. Lopez et. al conducted a randomized, crossover trial at two pediatric diabetes centers.  
Two different test meals (high fat and high protein) were given containing equivalent 
carbohydrate and insulin was dosed according to carbohydrate counting, the Pankowska 
Equation, or the Food Insulin Index (FII).  Postprandial glucose was measured for 300 minutes 
(5 hours) using continuous glucose monitoring.  Mean insulin dose for carbohydrate counting 
was constant across test meals.  Authors reported peak glucose excursion as significantly higher 
for carbohydrate counting and FII when compared to the Pankowska Equation (mean difference 
for carbohydrate counting vs. the Pankowska Equation =1.28 p <.02 for carbohydrate counting 
and FII) after adjusting for meal type.  No significant difference was found between 
carbohydrate counting and FII.  Percentage of time in target range was also lower using the 
Pankowska equation following both high fat and high protein meals [mean difference for 
carbohydrate counting vs. the Pankowska Equation = 13.6, p = 0.018) (mean difference FII vs. 
Pankowska Equation = 15.3 (p = 0.010)]; however, Lopez et al noted a significant increase in 
hypoglycemia.(42) While the Pankowska equation appeared to result in the greatest reduction in 
post-prandial hyperglycemia when compared with dosing based on the FII and ICR, it also 
resulted in a significant increase in hypoglycemia, suggesting the need to adjust dosing in some 
individuals with type 1 diabetes. 
 
1 Nutrient Data Laboratory (U.S.), and Consumer and Food Economics Institute (U.S.). 1999. USDA nutrient database for standard 
reference. Riverdale, Md: USDA, Nutrient Data Laboratory, Agricultural Research Service. 
TIR = Time in Range 
iAUC= incremental Area under Curve 
ICR= Insulin to carb ratio 
IR = Insulin Ratio 
FPU = Fat protein unit 
IV. Future Research Needs and Implications for Practice 
Table 2: Doses for Different meals using 15:1 Insulin to Carb Ratio 
Meal  Nutrition Facts1 ICR 
(1u/15 g 
CHO) 
MPB FII Warsaw Formula 
1 cup Kraft 
Macaroni And 
Cheese 
(HFMPHC) 
Kcal: 376  
CHO: 47 g (50%) 
Total Fat: 16 g 
(39%) 
Protein: 9.7 g (10%) 
3.13 u Varies based on 
individual 
5.4 u  5.87 u total: 
3.13 u 
immediately 
+ 2.74 u over 3.8 
hrs. 
6 oz. Beef 
Tenderloin 
(HFHPLC) 
Kcal: 330 
CHO: 0 g (0%) 
Total Fat: 15 g 
(38%) 
Protein: 54 g (58%) 
0 u Varies based on 
individual 
5.5 u 5.55 u total: 
0 u immediately 
5.55 u over 8 
hrs. 
3 oz. Fish (ling) 
+ 1/2 cup brown 
rice 
(LFHPHC) 
Kcal: 345 
CHO: 39 g (45%) 
Total Fat: 2.74 g 
(7%) 
Protein: 40.8 g 
(47%) 
2.6 u Varies based on 
individual 
7.1 u 5.4 u total: 
2.6 u 
immediately 
2.8 u over 3.87 
hrs. 
 
100 g Mashed 
potatoes 
LFLPHC 
Kcal: 364 
CHO: 81.82 g (90%) 
Fat: 0 g (0%) 
Protein: 9.09 g 
(10%) 
 
5.5 u Varies based on 
individual 
15.1 u 5.5 u total 
immediately 
  
While there is significant evidence that dietary fat and protein impact blood glucose, specifically 
causing delayed post-prandial hyperglycemia in patients with type 1 diabetes, there are 
significant gaps in the literature that need be addressed to improve guidelines on mealtime 
insulin dosing to account for fat and protein. 
 
First, more research is needed on the impact of various types and sources of fat and protein on 
postprandial glycemia.  While Bell et. al found no significant differences across different fat-
containing foods, Bozzetto et. al found that olive oil, a food high in monounsaturated fatty acids, 
improved post-prandial blood glucose when compared with butter.(24, 25) A large systematic 
review and meta-analysis that examined randomized controlled feeding trials in adults found 
differing glycemic responses to different types of fat overall and more specifically that 
polyunsaturated fatty acids consistently improved glycemia.(21) This suggests that more 
research is warranted on the differing effects of different sources of fat on blood glucose, and 
future research on dosing may consider type of fat in addition to quantity. 
 
Similarly, more research is warranted on the impact of different protein sources and protein 
types.  Most studies that have exclusively examined the impact of protein on postprandial 
glycemia have utilized whey protein (a protein in milk) in test meals.(30, 31)  There is, however, 
less information on the impact of other protein types and sources.  Not all amino acids are 
glucogenic, meaning that not all amino acids may be converted into glucose.  More research is 
needed on how different protein sources and amino acid compositions impact blood glucose in 
patients with type 1 diabetes to improve mealtime dosing recommendations. 
 
One challenge to improving dosing methods is the amount of individual variability observed in 
many studies (table 1).  While these dosing models appear effective for some participants with 
type 1 diabetes, studies suggest a range of insulin needs that varies based on the participant, with 
some dosing models resulting in post-prandial hypoglycemia in some individuals and 
hyperglycemia in others.(24, 36, 39, 41, 43)  Dosing models may need to be adjusted to the 
individual’s response to fat and protein, suggesting the need for both guidance from a registered 
dietitian or other clinician, and potentially the future role of individualized or precision nutrition 
in diabetes management. 
 
Another consideration is the challenge of translating a complicated dosing regimen, and teaching 
a dosing method in the clinic setting.  While carbohydrate counting is currently standard of 
practice, adherence and accuracy are both concerns with carbohydrate counting.  A number of 
studies have suggested that accuracy of estimating carbohydrates tends to be low in patients with 
type 1 diabetes.  One study found that adults with type 1 diabetes estimated carbohydrates with 
59% accuracy, and it has been suggested that accuracy and adherence may be even lower in 
adolescents and young adults with type 1 diabetes.(44) Any proposed dosing model would need 
to be simple enough to be translated effectively to the clinic setting, but currently many proposed 
models involve complex predictive modeling based on individual profile (MPB) or complicated 
calculations based on observed insulin response to specific foods (FII).   
 
The complexity of dosing models suggests the possible role of technology in determining 
mealtime dosing based on macronutrient content.  Mobile apps and newer hybrid closed loop 
 algorithms may be employed to optimize and even possibly individualize dosing.  Currently, 
only unofficial DIY Loop systems allow for the input of high fat or high protein meals.  Future 
algorithms may also consider similar mealtime dosing systems to better account for the delayed 
hyperglycemia experienced by many after a high fat high protein meal. 
 
Finally, future research may consider the long-term impact of specific dietary patterns on insulin 
sensitivity and risk of complications. A recent qualitative paper suggested that use of a closed-
loop system may promote less restraint with regard to dietary choices and may lead to increased 
consumption of higher fat, and more energy-dense foods. (45) While this review did not consider 
the long-term impact of diet composition, professionals delivering medical nutritional therapy 
and/or providing dosing education for patients with type 1 diabetes may consider risk of weight 
gain, increased insulin resistance, and risk for complications. 
 
Conclusions  
Dietary fat and protein cause delayed post-prandial hyperglycemia in patients with type 1 
diabetes via a variety of complex interconnected mechanisms, and there is considerable 
individual variability in glycemic response to dietary fat and protein.  Recent research in patients 
with type 1 diabetes supports the need for improved dosing models that account for fat and 
protein content in meals; however, only a handful of models have been proposed and studied, 
typically within a small and homogenous population.  More research on these dosing models is 
needed in larger representative samples within various settings to better assess the feasibility and 
efficacy of these different models. 
Technology, such as continuous glucose monitoring and automated insulin systems may be 
useful in addressing individual difference in response to meal composition.  According to data 
from the T1D Exchange Registry, continuous glucose monitoring has increased from 7% in 
2010-2012 to 30% in 2016-2018.(2) Automated insulin systems are also becoming increasingly 
available with one commercially available hybrid closed loop system and multiple others 
currently under FDA review.  Reviewing CGM trends and dose history when available and 
asking patients about meal composition may be helpful in adjusting mealtime insulin dose to suit 
individual needs.  The rapid development and increasing availability of these new technologies 
such as automated insulin delivery systems in combination with continuous glucose monitoring 
will allow for development and refinement of algorithms and dosing models accounting for fat 
and protein composition that will meet individual needs. 
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